SEM Semperit Holding AG

EQS-News: Semperit finalizes sale of the remaining medical business

EQS-News: Semperit AG Holding / Key word(s): Disposal
Semperit finalizes sale of the remaining medical business

01.07.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Semperit finalizes sale of the remaining medical business

Vienna, July 1, 2024 – Semperit has completed the sale of the medical business and transferred the remaining production and packaging of surgical gloves to the buyer of the entire medical business, the Southeast Asian Harps Global, as agreed. Combined under the discontinued operations “Surgical Operations”, these activities were most recently carried out as contract manufacturing for Harps Global.

“After we had already sold and handed over the majority of the glove business to Harps in 2023, we have now been able to place the remaining part in the hands of the new, responsible owner early and terminate the contract manufacturing. This means that Semperit has exited the glove business completely, and we are concentrating 100% on implementing our growth strategy as a leading specialist in elastomer products for industry,” says Semperit’s CEO Karl Haider.

The second and final closing of the sale of the medical business took place with effect from June 30, 2024, and comprised the sale of the operation for the contract manufacturing of surgical gloves in Wimpassing, Austria, and the 100% stake in the Hungarian company Sempermed Kft., which carries out their packaging in Sopron, Hungary. The sales price (cash and debt free) amounts to EUR 7 million and is subject to the usual price adjustment mechanisms.

 

Contact:

Bettina Schragl
Director Group Communications, IR and     Brands/Spokeswoman
57
.com
Judit Helenyi
Director Investor Relations
 
10

 

 

 

About Semperit


The publicly listed Semperit AG Holding is an internationally oriented group of companies that develops, produces and sells high-quality elastomer products and applications for industrial customers in over 100 countries worldwide through its two divisions Semperit Industrial Applications and Semperit Engineered Applications. With its highly efficient production and cost leadership, the Semperit Industrial Applications division focusses on industrial applications in connection with large-scale production, including hydraulic and industrial hoses as well as profiles. The Semperit Engineered Applications division comprises the production of escalator handrails, conveyor belts, cable car rings, other engineered elastomer products, as well as the Rico Group, and focuses on customized technical solutions. The traditional Austrian company was founded in 1824 and is headquartered in Vienna. The Semperit Group employs around 4,300 people worldwide and has 16 production sites and numerous sales offices in Europe, Asia, Australia and America. In the 2023 financial year, the Group generated revenue of EUR 721.1 million and EBITDA of EUR 71.8 million.



01.07.2024 CET/CEST This Corporate News was distributed by EQS Group AG.


Language: English
Company: Semperit AG Holding
Am Belvedere 10
1100 Wien
Austria
Phone: 0
Fax: 2
E-mail:
Internet:
ISIN: AT0000785555
Listed: Vienna Stock Exchange (Official Market)
EQS News ID: 1936229

 
End of News EQS News Service

1936229  01.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1936229&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
01/07/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Semperit Holding AG

 PRESS RELEASE

EQS-News: Semperit steigert Profitabilität im ersten Halbjahr 2024

EQS-News: Semperit AG Holding / Schlagwort(e): Halbjahresergebnis/Sonstiges Semperit steigert Profitabilität im ersten Halbjahr 2024 13.08.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Semperit steigert Profitabilität im ersten Halbjahr 2024   EBITDA-Plus von 8% auf 47,3 Mio. EUR, Ergebnis nach Steuern mehr als verdoppelt Free Cashflow auf 23,6 Mio. EUR deutlich verbessert Sparprogramm greift: Kostensenkungen von 14,4 Mio. EUR, davon 8,6 Mio. EUR im H1 EBITDA-Guidance für 2024 mit rund 80 Mio. EUR bestätigt Mittel...

 PRESS RELEASE

EQS-News: Semperit increases profitability in the first half of 2024

EQS-News: Semperit AG Holding / Key word(s): Half Year Results/Miscellaneous Semperit increases profitability in the first half of 2024 13.08.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Semperit increases profitability in the first half of 2024   EBITDA up 8% to EUR 47.3 million, earnings after tax more than doubled Free cash flow significantly improved to EUR 23.6 million Cost-cutting program takes effect: cost reductions of EUR 14.4 million, of which EUR 8.6 million in H1 EBITDA guidance confirmed at around EUR 80 mi...

 PRESS RELEASE

EQS-News: Semperit schließt Verkauf des verbliebenen Medizingeschäfts ...

EQS-News: Semperit AG Holding / Schlagwort(e): Verkauf Semperit schließt Verkauf des verbliebenen Medizingeschäfts ab 01.07.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Semperit schließt Verkauf des verbliebenen Medizingeschäfts ab Wien, 1. Juli 2024 – Semperit hat den Verkauf des Medizingeschäfts komplett abgeschlossen und die noch verbliebene Produktion und Verpackung von Operationshandschuhen wie vereinbart an den Käufer des gesamten Medizingeschäfts, die südostasiatische Harps Global, übergeben. Diese Tätigkeiten ...

 PRESS RELEASE

EQS-News: Semperit finalizes sale of the remaining medical business

EQS-News: Semperit AG Holding / Key word(s): Disposal Semperit finalizes sale of the remaining medical business 01.07.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Semperit finalizes sale of the remaining medical business Vienna, July 1, 2024 – Semperit has completed the sale of the medical business and transferred the remaining production and packaging of surgical gloves to the buyer of the entire medical business, the Southeast Asian Harps Global, as agreed. Combined under the discontinued operations “Surgical Operations”,...

 PRESS RELEASE

EQS-News: Semperit: Vorstandsvorsitzender Karl Haider wird seinen Vert...

EQS-News: Semperit AG Holding / Schlagwort(e): Personalie Semperit: Vorstandsvorsitzender Karl Haider wird seinen Vertrag nicht verlängern 10.06.2024 / 11:20 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Semperit: Vorstandsvorsitzender Karl Haider wird seinen Vertrag nicht verlängern Wien, 10. Juni 2024 – Karl Haider hat heute dem Aufsichtsratsvorsitzenden der Semperit AG Holding mitgeteilt, dass er für eine Verlängerung seines am 31. März 2025 auslaufenden Vorstandsmandats nicht zur Verfügung stehen wird. Karl Haider, der mit 11. ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch